Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure.
| Last: | $0.6904 |
|---|---|
| Change Percent: | 12.26% |
| Open: | $0.658 |
| Close: | $0.615 |
| High: | $0.708 |
| Low: | $0.6301 |
| Volume: | 363,481 |
| Last Trade Date Time: | 03/06/2026 12:41:43 pm |
| Market Cap: | $10,616,869 |
|---|---|
| Float: | 6,613,929 |
| Insiders Ownership: | 0.01% |
| Institutions: | 18 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.calcimedica.com |
| Country: | US |
| City: | La Jolla |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about CalciMedica Inc. (NASDAQ: CALC).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.